Position in QGEN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$29,698,952
-$713,990 QoQ
Shares Held
759,564
0.0% QoQ
Ownership
0.368%
of shares outstanding
% of Portfolio
1.46%
of 13F equity value
Holder Rank
#44
of 332 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in QGEN Over Time
Shares Held
Position Value (USD)
Derivatives in QGEN
reported options exposure · as of Sep 30, 2024CallValue
$100,254
CallShares
2,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026DNCA FINANCE holds $37,781,203 across 3 Diagnostics & Research names. QGEN ranks #1 (78.6% of the industry book) .
All Filings in QGEN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,698,952 | 759,564 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $30,412,942 | 759,564 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $31,111,190 | 691,821 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $24,952,931 | 558,481 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $24,963,229 | 519,418 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $21,148,008 | 526,725 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $24,417,179 | 548,331 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $100,254 | 2,200 | Call | Defined | 2024-11-13 | |
| 2024-09-30 | $18,628,104 | 408,780 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $16,796,770 | 408,780 | Shares | Defined | 2024-07-15 | |
| 2024-06-30 | $90,398 | 2,200 | Call | Defined | 2024-07-15 | |
| No filing history on record for this holder in this stock. | ||||||